Loading…
Electronic Permitting Modernization Act
Legislative Progress
Introduced
September 14, 2023
Latest Action
September 25, 2024
Primary Sponsor
Katie PorterDemocratic(CA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
92pct
377d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2026 · first_quarter · Health Issues
S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 891: Bipartisan Health Care Act (including section 227 - Modernizing and Ensuring PBM Accountability) S. 932: Give Kids a Chance Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: H.R. 1492, Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025. To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act H.R. 6423: HELP Copays Act H.R. 7837: Most Favored Patients Act H.R. 7953: FAIR ACT Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) SECURE Act of 2026 (draft) Biopharmaceutical innovation policy issues User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues MAHA Commission Report - Make Our Children Healthy Again Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Section 340B Public Health Services Act 340B engagement and MFN related engagement Provisions related to the 340B program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues S. 5459: Biosimilars Access and Affordability Act (118th Congress) Drug shortages policy issues Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First Presidential Memoranda: Memorandum for the Secretary of Health and Human Services the Commissioner of Drugs - Addressing Misleading Direct-to-Consumer Prescription Drug Advertisements Biopharmaceutical innovation and pricing issues HR 5509, Safe Step Act, Provisions related step therapy protocols Tariff and MFN issues VICP Bill
Received in the Senate and Read twice and referred to the Committee on Energy and Natural Resources.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5729-5730)
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5729-5730)
DEBATE - The House proceeded with forty minutes of debate on H.R. 5509.
Considered under suspension of the rules. (consideration: CR H5729-5731)
Mr. Westerman moved to suspend the rules and pass the bill, as amended.
Placed on the Union Calendar, Calendar No. 577.
Reported (Amended) by the Committee on Natural Resources. H. Rept. 118-682.
Congress.gov source codes: 5000, H12200
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $1,640,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2024 · fourth_quarter · Energy/Nuclear
HR 10545 American Relief Act, 2025 (provisions related to permitting reform, E15 fuel and the manning and crewing of offshore oil and gas construction vessels); HR 5009 Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 (provisions related to permitting reform and the manning and crewing of offshore oil and gas vessels); HR 5509 Electronic Permitting Modernization Act; S 4753 Energy Permitting Reform Act of 2024 (Titles I-IV and Title VI); draft legislation on permitting modernization for leases on federal lands and pipelines; draft legislation on reforming the Endangered Species Act.
Client expense: $1,270,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Energy/Nuclear
HR 5509 Electronic Permitting Modernization Act; HR 6285 Alaskas Right to Produce Act of 2023; HR 6494 Promoting Innovation in Pipeline Efficiency and Safety Act of 2023; HR 7655 Pipeline Safety, Modernization, and Expansion Act of 2024; HR 8070 Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 (provisions related to the manning and crewing of foreign specialized offshore oil and gas vessels; Sec. 313); HR 8204 Regulatory Early Notice and Engagement Act of 2024; draft legislation on the National Defense Authorization Act for Fiscal Year 2025 (provisions related to disclosure of greenhouse gas emissions and climate-related financial risk); draft legislation on permitting modernization for leases on federal lands and pipelines; draft legislation on Pipeline Safety Reauthorization.
Client expense: $1,690,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Ordered to be Reported in the Nature of a Substitute (Amended) by Unanimous Consent.
Committee Consideration and Mark-up Session Held
Subcommittee on Water, Wildlife, and Fisheries Discharged
Subcommittee Hearings Held
Referred to the Subcommittee on Water, Wildlife, and Fisheries.
Referred to the House Committee on Natural Resources.
Introduced in House
Congress.gov source codes: 1000, Intro-H
| House |
| Discharged from |
| November 15, 2023 |
| Natural Resources Committee | House | Referred To | September 14, 2023 |
| September 14, 2023 |
| Democratic |
| AK |
| Sean Casten | Democratic | IL |